Clinical Trial Update: Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reversal of rocuronium with sugammadex versus succinylcholine in electroconvulsive therapy completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Electroconvulsive Therapy Indications

Drugs mentioned

• Rocuronium (rocuronium bromide)
• Succinylcholine (succinylcholine chloride)
• Sugammadex (sugammadex)

Snippet

Sponsor: University of California, San Francisco | Conditions: Neuromuscular Blockade | Phase 2 | Status: COMPLETED | Results posted: 2023-09-08